Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:BDMD NASDAQ:LUNG NASDAQ:PETV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$1.99-1.5%$2.14$0.76▼$2.73$76.39M1.3983,281 shs17,889 shsBDMDBaird Medical Investment$2.45+5.2%$2.95$1.05▼$12.50$83.25M-1262,909 shs220,096 shsLUNGPulmonx$1.71-2.8%$2.34$1.47▼$9.37$71.71M0.43930,463 shs398,425 shsPETVPetVivo$0.85+6.3%$0.80$0.40▼$0.98$23.72M0.6618,895 shs1,157 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-1.49%-4.78%+4.74%+25.95%+51.91%BDMDBaird Medical Investment+5.15%+6.52%+17.22%-31.37%+244,999,900.00%LUNGPulmonx-2.84%+1.18%-45.71%-48.96%-77.08%PETVPetVivo+6.25%0.00%+7.59%+10.95%+41.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPYXApyx Medical2.1144 of 5 stars0.03.00.04.23.51.70.6BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/ALUNGPulmonx3.9033 of 5 stars4.34.00.00.02.63.30.6PETVPetVivoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate BuyN/AN/ABDMDBaird Medical Investment 0.00N/AN/AN/ALUNGPulmonx 2.56Moderate Buy$7.66348.20% UpsidePETVPetVivo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PETV, BDMD, APYX, and LUNG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/1/2025LUNGPulmonxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $3.007/31/2025LUNGPulmonxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$12.00 ➝ $8.007/31/2025LUNGPulmonxStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $5.007/31/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $16.007/31/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$9.00 ➝ $2.50(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$48.10M1.56N/AN/A$0.20 per share9.95BDMDBaird Medical Investment$37.04M2.36N/AN/AN/A∞LUNGPulmonx$83.79M0.83N/AN/A$1.70 per share1.01PETVPetVivo$1.05M22.67N/AN/A($0.03) per share-28.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%11/7/2025 (Estimated)BDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/ALUNGPulmonx-$56.39M-$1.43N/AN/AN/A-62.88%-69.76%-36.26%10/29/2025 (Estimated)PETVPetVivo-$10.95M-$0.40N/A∞N/A-902.82%-4,813.07%-281.78%11/13/2025 (Estimated)Latest PETV, BDMD, APYX, and LUNG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025APYXApyx Medical-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 million7/30/2025Q2 2025LUNGPulmonx-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/ABDMDBaird Medical InvestmentN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical4.614.723.95BDMDBaird Medical InvestmentN/AN/AN/ALUNGPulmonx0.545.354.63PETVPetVivo0.020.420.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%BDMDBaird Medical Investment19.78%LUNGPulmonx91.04%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%BDMDBaird Medical Investment78.90%LUNGPulmonx6.80%PETVPetVivo10.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.82 million32.07 millionOptionableBDMDBaird Medical InvestmentN/A35.73 million7.54 millionN/ALUNGPulmonx25040.75 million37.98 millionOptionablePETVPetVivo2027.90 million19.06 millionNot OptionablePETV, BDMD, APYX, and LUNG HeadlinesRecent News About These CompaniesPetVivo Holdings, Inc.: PetVivo Reports Fiscal Q1 2026 ResultsAugust 16, 2025 | finanznachrichten.dePetVivo Holdings, Inc. (PETV) Q1 2026 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comPetVivo Reports Fiscal Q1 2026 ResultsAugust 14, 2025 | globenewswire.comPetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ETAugust 7, 2025 | globenewswire.comPetVivo Holdings Inc. to Trade on OTCQX Best MarketJuly 30, 2025 | globenewswire.comPetVivo Holdings, Inc. (OTC:PETV) Q4 2025 Earnings Call TranscriptJuly 3, 2025 | insidermonkey.comPetVivo Reports Fiscal 2025 Results - Seeking AlphaJuly 2, 2025 | seekingalpha.comPetVivo Reports Fiscal 2025 Results - MorningstarJuly 2, 2025 | morningstar.comMPetVivo Holdings, Inc.: PetVivo Reports Fiscal 2025 ResultsJuly 1, 2025 | finanznachrichten.dePetVivo Holdings Inc (PETV) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ExpansionJuly 1, 2025 | finance.yahoo.comPetVivo Holdings, Inc. (PETV) Q4 2025 Earnings Call TranscriptJune 30, 2025 | seekingalpha.comPetVivo Reports Fiscal 2025 ResultsJune 30, 2025 | globenewswire.comPetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ETJune 26, 2025 | globenewswire.comPetVivo Holdings completes $5 million preferred stock offeringJune 26, 2025 | investing.comPetVivo Holdings Completes $5M Equity Financing InitiativeJune 24, 2025 | tipranks.comPETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGJune 24, 2025 | globenewswire.comPETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGJune 20, 2025 | globenewswire.comPetVivo Holdings Secures $3 Million from Equity OfferingJune 20, 2025 | tipranks.comPetVivo Holdings Secures $200K in Equity FinancingJune 16, 2025 | tipranks.comNew to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and CommercialvilleJune 6, 2025 | indystar.comINew MarketBeat Followers Over TimeMedia Sentiment Over TimePETV, BDMD, APYX, and LUNG Company DescriptionsApyx Medical NASDAQ:APYX$1.99 -0.03 (-1.49%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.98 -0.01 (-0.75%) As of 08/29/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Baird Medical Investment NASDAQ:BDMD$2.45 +0.12 (+5.15%) As of 08/29/2025 04:00 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Pulmonx NASDAQ:LUNG$1.71 -0.05 (-2.84%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.71 +0.00 (+0.23%) As of 08/29/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.PetVivo NASDAQ:PETV$0.85 +0.05 (+6.25%) As of 08/29/2025 01:43 PM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
